A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease

Huntington’s disease (HD) is a neurodegenerative disorder, of which pathogenesis is caused by a polyglutamine expansion in the amino-terminus of huntingtin gene that resulted in the aggregation of mutant HTT proteins. HD is characterized by progressive motor dysfunction, cognitive impairment and neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Endan, Choi, Jiwoo, Sim, Hye-Ri, Kim, Jiyeon, Jun, Jae Hyun, Kyung, Jangbeen, Ha, Nina, Kim, Semi, Ryu, Keun Ho, Chung, Seung Soo, Kim, Hyun Sook, Lee, Sungsu, Seol, Wongi, Song, Jihwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068348/
https://www.ncbi.nlm.nih.gov/pubmed/36593104
http://dx.doi.org/10.5483/BMBRep.2022-0157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068348/
https://www.ncbi.nlm.nih.gov/pubmed/36593104
http://dx.doi.org/10.5483/BMBRep.2022-0157

Ejemplares similares